ERBB2 and endometrial cancer: Another study by Morrison et al. showed that higher HER-2/neu expression is correlated with shorter disease-specific survival and progression-free survival in endometrial cancers; in this study, high-grade tumors and serous ECs had significantly higher HER-2/neu expression (18).